(Q41686086)

7 October 2017

A concise critical analysis of serologic testing for the diagnosis of lyme disease (English)

1 reference

7 October 2017

0 references

Roberta L DeBiasi

1

1 reference

7 October 2017

1 December 2014

1 reference

Current infectious disease reports

7 October 2017

1 reference

7 October 2017

16

1 reference

7 October 2017

12

1 reference

7 October 2017

450

1 reference

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

7 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Asymptomatic Infection with Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Common misconceptions about Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Prospective study of serologic tests for lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Diagnosis of lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Laboratory testing for suspected Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Evaluation of tests for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Lyme wars: let's tackle the testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Diagnosis and treatment of Lyme arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-014-0450-9

Concerns regarding a new culture method for Borrelia burgdorferi not approved for the diagnosis of Lyme disease

21 January 2018

1 reference

12 December 2020

Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease

1 reference

12 December 2020

Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis

1 reference

12 December 2020

1 reference

12 December 2020

The Presenting Manifestations of Lyme Disease and the Outcomes of Treatment

1 reference

12 December 2020

10.1007/S11908-014-0450-9

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

25351855